HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 20 of 54
 next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleNomoto, Hiroshi; Oba-Yamamoto, Chiho; Takahashi, Yuka; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, HideakiEffects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes : Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)-Diabetes Therapy-Mar-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium–glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of Diabetes Investigation-Feb-2021
articleChiba, Koki; Nomoto, Hiroshi; Nakamura, Akinobu; Cho, Kyu Yong; Yamashita, Kumiko; Shibayama, Yui; Miya, Aika; Kameda, Hiraku; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiSodium-glucose cotransporter 2 inhibitors reduce day-to-day glucose variability in patients with type 1 diabetes-Journal of diabetes investigation-Feb-2021
articleNakamura, Akinobu; Miyoshi, Hideaki; Ukawa, Shigekazu; Nakamura, Koshi; Nakagawa, Takafumi; Terauchi, Yasuo; Tamakoshi, Akiko; Atsumi, TatsuyaInverse correlation between serum high‐molecular‐weight adiponectin and proinsulin level in a Japanese population : the DOSANCO Health Study-Journal of Diabetes Investigation-Jan-2021
articleBaba, Natsuki; Kameda, Hiraku; Nakamura, Akinobu; Yong Cho, Kyu; Nomoto, Hiroshi; Mitsuhashi, Tomoko; Miyoshi, Hideaki; Atsumi, TatsuyaSilent pituitary adenoma and metabolic disorders : obesity, abnormal glucose tolerance, hypertension and dyslipidemia-Endocrine Journal-2021
articleTakahashi, Kiyohiko; Nakamura, Akinobu; Furusawa, Sho; Yokozeki, Kei; Sugawara, Hajime; Yanagisawa, Hideyuki; Akikawa, Kazumasa; Kikuchi, HideakiInitial dip predicts renal protective effects after the administration of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease with normoalbuminuria-Journal of Clinical and Translational Endocrinology-Dec-2020
articleMiya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Ukawa, Shigekazu; Nakamura, Koshi; Nakagawa, Takafumi; Terauchi, Yasuo; Tamakoshi, Akiko; Atsumi, TatsuyaCorrelation between serum proinsulin levels and fatty liver : The Dynamics of Lifestyle and Neighborhood Community on Health Study Health Study-Journal of diabetes investigation-Jul-2020
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation : An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study)-Diabetes, Obesity and Metabolism-Mar-2020
articleKameda, Reina; Nomoto, Hiroshi; Cho, Kyu Yong; Kawata, Shinichiro; Omori, Kazuno; Takeuchi, Jun; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, HideakiEffects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study-BMJ Open-Feb-2020
articleNakamura, Akinobu; Miyoshi, Hideaki; Kameda, Hiraku; Yamashita, Kumiko; Kurihara, YoshioImpact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria-Diabetology and metabolic syndrome-10-Jan-2020
articleNakamura, Akinobu; Miyoshi, Hideaki; Ukawa, Shigekazu; Nakamura, Koshi; Nakagawa, Takafumi; Terauchi, Yasuo; Tamakoshi, Akiko; Atsumi, TatsuyaProinsulin is sensitive to reflect glucose intolerance-Journal of diabetes investigation-Jan-2020
articleShibayama, Yui; Wada, Norio; Baba, Shuhei; Obara, Shinji; Sakai, Hidetsugu; Usubuchi, Hiroaki; Terae, Satoshi; Nakamura, Akinobu; Atsumi, TatsuyaThe risk factors for hepatic steatosis in patients with primary aldosteronism-Endocrine journal-2020
articleMiyoshi, Hideaki; Kameda, Hiraku; Yamashita, Kumiko; Nakamura, Akinobu; Kurihara, YoshioProtective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes-Journal of diabetes investigation-Nov-2019
articleShibayama, Yui; Kameda, Hiraku; Ota, Shoichiro; Tsuchida, Kazuhisa; Cho, Kyu Yong; Nakamura, Akinobu; Miyoshi, Hideaki; Atsumi, TatsuyaCase of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab-Journal of diabetes investigation-Sep-2019
articleMiya, Aika; Nakamura, Akinobu; Kameda, Hiraku; Nozu, Kandai; Miyoshi, Hideaki; Atsumi, TatsuyaGitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration A case report-Medicine-Jul-2019
articleTakase, Takahiro; Nakamura, Akinobu; Yamamoto, Chiho; Nomoto, Hiroshi; Miya, Aika; Dannoura, Midori; Cho, Kyu Yong; Kurihara, Yoshio; Manda, Naoki; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiImprovement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes : A randomized controlled trial-Journal of Diabetes Investigation-May-2019
articleNomoto, Hiroshi; Kameda, Hiraku; Nakamura, Akinobu; Tsuchida, Kazuhisa; Nagai, So; Atsumi, Tatsuya; Miyoshi, HideakiBreakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment-Frontiers in Endocrinology-1-Mar-2019
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiEffect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus : An open-label, prospective, randomized, parallel-group comparison trial-Diabetes, Obesity and Metabolism-Mar-2019
articleTakahashi, Kiyohiko; Cho, Kyu Yong; Nakamura, Akinobu; Miya, Aika; Miyoshi, Arina; Yamamoto, Chiho; Nomoto, Hiroshi; Niwa, Hirokatsu; Takahashi, Kiyohito; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Ito, Yoichi M; Atsumi, Tatsuya; Miyoshi, HideakiShould sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes-Journal of Diabetes Investigation-Mar-2019
articleOmori, Kazuno; Nomoto, Hiroshi; Nakamura, Akinobu; Takase, Takahiro; Cho, Kyu Yong; Ono, Kota; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiReduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide : A randomized controlled trial of repaglinide vs sulfonylurea-Journal of Diabetes Investigation-Mar-2019
Showing results 1 to 20 of 54
 next >

 

Hokkaido University